AMY POPE: Open Payments
NPI 1447601075 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,073 in 44 payments from 16 companies in 2025. Trend: 2023 $1,167 · 2024 $1,447 · 2025 $1,073
Food & beverage: $1,073
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $247 |
| Boston Scientific Corporation | 2 | $173 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $120 |
| Collegium Pharmaceutical, Inc. | 2 | $84 |
| Phathom Pharmaceuticals, Inc. | 3 | $65 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $61 |
| Regeneron Healthcare Solutions, Inc. | 2 | $48 |
| Celltrion USA Inc. | 2 | $46 |
| Madrigal Pharmaceuticals | 2 | $45 |
| QOL Medical, LLC | 2 | $45 |
Products named: Intracept, ENTYVIO, RINVOQ, DUPIXENT, Belbuca, LINZESS, VOQUEZNA, JOURNAVX.
Industry payments across NC — which companies pay providers there.
